Jessica Hagen
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
A study published in The New England Journal of Medicine found a closed-loop control system kept children's glucose levels in the target range longer than standard care.
Blood-collection device-maker Vitestro, tech-enabled baby bottle designer Emulait, digital health support platform Reveal HealthTech and AI-based testing platform PocDoc also received funding.
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
The collaboration will expand MedArrive's maternal care services for managed Medicaid health plan members.
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.
The company also announced a new payer network and revenue cycle management service.
The funds will be used to accelerate the adoption of the platform's applied behavior analysis-focused tools.
The acquisition expands the senior-focused company's offerings to include a workflow management program and value-based care reimbursement assistance.
Fire1, a remote patient monitoring company for heart failure patients, and Protai, an AI-powered drug discovery platform, scored funding.